Dr. Michael A. Gold, MD
- Medicare services, 2024
- 69,757
- Medicare patients, 2024
- 472
- Part D claims, 2024
- 710
- Clinical trials
- 1
- MIPS score, 2024
- 96
- Practice address
- 12697 E 51st S St, Tulsa, OK 74146
- Practice phone
- Call (918) 505-3200
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Oklahoma Cancer Specialists and Research Institute
Tulsa, Oklahoma
Find Dr. Gold's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael A. Gold is a gynecologic oncologist in Tulsa, Oklahoma
Dr. Gold practices at Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma.
Dr. Gold's NPI, 1376511956, was assigned on March 9, 2006. Dr. Gold graduated from Jefferson Medical College of Thomas Jefferson University in 1992. Dr. Gold holds Oklahoma license 19758.
- NPI
- 1376511956NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5597789115
- NPI enumeration date
- March 9, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (918) 505-3200
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 60
- Medical school graduation
- 1992
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael A. Gold practices at Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma
Dr. Gold's primary practice is Oklahoma Cancer Specialists and Research Institute, at 12697 E 51st S St, Tulsa, OK 74146 in Tulsa County. The practice phone is (918) 505-3200.
- Oklahoma Cancer Specialists and Research Institute12697 E 51st S St, Tulsa, OK 74146 · Tulsa CountyPhone(918) 505-3200
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Michael A. Gold is affiliated with 7 sites of care and 2 medical groups
Dr. Gold's primary practice is Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma. Dr. Gold is also affiliated with Saint Francis Hospital. The medical group on file is Oklahoma Cancer Specialists and Research Institute. Dmand AI also links Dr. Gold to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Michael A. Gold's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gold practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Oklahoma Cancer Specialists and Research Institute | Available with a free account |
| +6 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael A. Gold is one of 19 gynecologic oncologists in Oklahoma
Gynecologic oncology is Dr. Gold's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Gold is licensed in Oklahoma.
Specialties and state licenses
- Gynecologic oncology, OklahomaPrimary
Gynecologic oncologists near Dr. Gold
Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael A. Gold billed Medicare for 69,757 services in 2024
CMS data shows 69,757 Medicare services from Dr. Gold across 54 procedure codes in 2024, for 472 Medicare patients. Medicare paid $534,668 for them.
Dr. Gold's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 58,8752024: 58,4151%
- Other services
- 2023: 6,2392024: 6,97612%
- Lab and pathology
- 2023: 2,9292024: 2,46216%
- Tests and treatments
- 2023: 1,3622024: 1,18513%
- Office and hospital visits
- 2023: 3862024: 44415%
- Surgery
- 2023: 1032024: 17166%
- Imaging
- 2023: 942024: 10411%
Where Dr. Gold's Medicare services took place, 2024
- In an office69,704100%
- In a facility530%
Dr. Gold compared with the Oklahoma median for gynecologic oncologists, 2024
- Dr. Gold
- Oklahoma median
- Medicare services
- 69,757vs 372187.5 times
- Medicare patients
- 472vs 1433.3 times
- Part D claims
- 491vs 1034.8 times
Medians across 20 gynecologic oncologists in Oklahoma with Dmand AI profiles that report each measure.
Dr. Gold's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Gold?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gold and other gynecologic oncologists in Oklahoma.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Michael A. Gold treated 472 Medicare patients in 2024, average age 73
CMS counts 472 Medicare patients who saw Dr. Gold in 2024. The largest group is 65 to 74, with 214 patients. 75% of them have high blood pressure, and 61% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Gold's median patient age at 69, with 86% women.
Dr. Gold's Medicare patients by age, 2024
Dr. Gold's Medicare patients by sex, 2024
- Women34673%
- Men12627%
Chronic conditions among Dr. Gold's Medicare patients, 2024
- High blood pressure75%
- High cholesterol61%
- Cancer48%
- Arthritis45%
- Mood disorders30%
- Chronic kidney disease29%
- Anxiety28%
- Depression28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Gold's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women86%
- Men14%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Michael A. Gold wrote 710 Medicare Part D claims in 2024
In 2024, Dr. Gold wrote 710 Medicare Part D claims for 176 patients. 91% of them were for generic drugs. CMS names the drug for 491 of them, across 22 drugs with 11 or more claims each, at $312,627 in total drug cost. In 2023, CMS named 635 claims across 27 drugs.
Dr. Gold's Part D claims by kind of drug, 2024
- Generic643 claims91%
- Brand-name67 claims9%
Dr. Gold's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Gold's Part D claims, 2024
- Opioids14%99 of 710 claims
- Antibiotics10%74 of 710 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6352024: 49123%
Drugs named by CMS: 22 in 2024, 27 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Michael A. Gold scored 96 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Gold for performance year 2024, reported individually. Dr. Gold accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of removal of the uterus by Dr. Gold, more than 87% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
Dr. Gold's MIPS scores, performance year 2024
- 96of 100Final score
- 83of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Where Dr. Gold ranks in Medicare procedure volume
- Removal of the uterus
- 87th percentile13 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael A. Gold has worked on 1 clinical trial
Dmand AI links Dr. Gold to 1 clinical trial. Conditions studied include Ovarian Neoplasms and Ovarian Diseases. Open Payments lists research payments to Dr. Gold that name 1 trial.
Conditions in Dr. Gold's trials
- Ovarian Neoplasms
- Ovarian Diseases
Investigators on the most trials with Dr. Gold
- Atrayee Basu Mallick, MD1 shared trial
- Maria C. Bell, MD1 shared trial
- Joseph Buscema, MD1 shared trial
Recent clinical trials with Dr. Gold
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael A. Gold received $17,800 in industry payments from 2017 to 2025
CMS Open Payments shows 70 general payments to Dr. Gold from 23 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 66% of the total. Seagen Inc. paid the most, $5,106. It also lists 5 research payments totaling $2,413 from 2018 to 2021, naming 1 clinical trial.
General payments to Dr. Gold by program year, 2017 to 2025
General payments to Dr. Gold by kind, 2017 to 2025
- Consulting fees$11,81066%
- Travel and lodging$3,51120%
- Food and beverage$2,21112%
- Education$2551%
- Gifts$140%
Companies that paid Dr. Gold the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael A. Gold graduated from Jefferson Medical College of Thomas Jefferson University
Dr. Gold graduated from Jefferson Medical College of Thomas Jefferson University in 1992.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Michael A. Gold's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael A. Gold
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael A. Gold's NPI number?
Dr. Michael A. Gold's NPI number is 1376511956. It was assigned on March 9, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael A. Gold?
Dr. Michael A. Gold is a gynecologic oncologist in Tulsa, Oklahoma. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).
Where does Dr. Michael A. Gold practice?
Dr. Gold practices at 12697 E 51st S St, Tulsa, OK 74146. Dr. Gold's primary practice is Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma. Dmand AI also links Dr. Gold to 3 hospitals, 2 group practices and clinics and 1 medical group.
What is Dr. Michael A. Gold's office phone number?
The practice phone on file for Dr. Gold is (918) 505-3200.
What is Dr. Michael A. Gold's medical license number?
Dr. Gold holds Oklahoma license 19758.
Which hospitals is Dr. Michael A. Gold affiliated with?
Dr. Gold is affiliated with Saint Francis Hospital. Dmand AI links Dr. Gold to 3 more hospitals.
What medical group is Dr. Michael A. Gold part of?
Dr. Gold is linked to Oklahoma Cancer Specialists and Research Institute. Dmand AI links Dr. Gold to 1 more medical group.
Does Dr. Michael A. Gold accept Medicare?
Yes. CMS data shows Dr. Gold billed Medicare for 69,757 services in 2024, and Dr. Gold accepts Medicare assignment.
What is Dr. Michael A. Gold's MIPS score?
Dr. Gold's MIPS final score for performance year 2024 is 96 out of 100, reported individually.
How many Medicare patients does Dr. Michael A. Gold see?
CMS counts 472 Medicare patients who saw Dr. Gold in 2024, with an average age of 73.
Show 6 more questionsShow fewer questions
What services does Dr. Michael A. Gold bill to Medicare?
In 2024, Dr. Gold's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J9263) and injected or infused drug (J9271).
Where did Dr. Michael A. Gold go to medical school?
Dr. Gold graduated from Jefferson Medical College of Thomas Jefferson University in 1992.
What drugs does Dr. Michael A. Gold prescribe most?
In 2024 Medicare Part D data, Dr. Gold's most prescribed drugs by claims were Oxycodone HCl, Prochlorperazine Maleate and Ondansetron HCl.
Has Dr. Michael A. Gold received payments from drug or device companies?
CMS Open Payments shows $17,800 in general payments to Dr. Gold from 23 companies from 2017 to 2025. The largest total came from Seagen Inc.
How long has Dr. Michael A. Gold been practicing?
Dr. Gold graduated from medical school in 1992, 34 years ago.
Does Dr. Michael A. Gold do research?
Dr. Gold has worked on 1 clinical trial.
Selling to gynecologic oncology practices?
See gynecologic oncologists in Oklahoma by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card